U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm Fuji Soft, after ...

Bain Capital may withdraw tender offer for Fuji Soft, after KKR raised bid in intense bidding war. Global investors target ...

Bain Capital disclosed that it is considering the "option of withdrawing" its hostile $4.2 billion takeover bid for Japanese ...

Bain Capital is considering withdrawing its tender offer for Japanese IT firm Fuji Soft after rival U.S. private equity giant ...

In a statement, Bain said that it is 'carefully considering' its future policy, including 'the option of withdrawing' its ...

TOKYO -- The jockeying to acquire Fuji Soft has exposed a hole in Japanese tender offer regulations that has allowed Bain Capital to vie with fellow U.S.-based private equity firm KKR without going ...

TOKYO -- U.S. private equity firm Bain Capital said Monday that backing down on a proposed tender offer for Japanese systems ...

KKR & Co's fourth-quarter assets under management fell short of expectations on Tuesday, dampening the optimism ...

Increased tender offer price aims to resolve uncertainty around FUJI SOFT’s privatization and enable KKR to focus on value creation efforts alongside the Company post privatization KKR ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...